v3.22.2.2
SHARE-BASED COMPENSATION
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION

NOTE 12 - SHARE-BASED COMPENSATION

 

Generally accepted accounting principles require share-based payments to employees, including grants of employee stock options, warrants, and common stock to be recognized in the income statement based on their fair values at the date of grant, net of estimated forfeitures.

 

In total, the Company recorded $476,805 and $416,119 of stock-based compensation for the six months ended June 30, 2022 and 2021, respectively, including shares to be issued related to consultants and board member stock options and common stock and warrants issued to non-employees. Included in stock subscription payable is accrued stock-based compensation of $1,284,723 and $873,799 at June 30, 2022 and December 31, 2021, respectively.

 

The Company used the Black-Scholes option pricing model to estimate the grant-date fair value of option and warrant awards:

 

  Expected Dividend Yield - because the Company does not currently pay dividends, the expected dividend yield is zero;
  Expected Volatility in Stock Price - volatility based on the Company’s trading activity was used to determine expected volatility;
  Risk-free Interest Rate - reflects the average rate on a United States Treasury Bond with a maturity equal to the expected term of the option; and
  Expected Life of Award - because we have minimal experience with the exercise of options or warrants for use in determining the expected life of each award, we used the option or warrant’s contractual term as the expected life.

 

In total for the six months ended June 30, 2022 and 2021, the Company recorded $7,682 and $8,607, respectively, of share-based compensation expense related to employee and Board Members’ stock options. The unrecognized compensation expense as of June 30, 2022 was $3,688 for non-vested share-based awards to be recognized over a period of less than one year.

 

Options

 

During 2004, the Board of Directors of the Company adopted a stock option plan (the “Plan”) and authorized up to 4,000,000 shares to be issued under the Plan. In April 2009, the Company’s Board of Directors authorized an increase in the number of shares to be issued under the Plan to 10,000,000 shares and to include the independent Board Members in the Plan in lieu of continuing the previous practice of granting warrants each quarter to independent Board Members for services. At June 30, 2022, there are 2,251,729 shares of common stock available for issuance under the Plan. In 2014, the Board of Directors adopted an additional stock option plan which provides for an additional 5,000,000 shares which are all available as of June 30, 2022. In 2019, the Board of Directors adopted an additional stock option plan with provides for 50,000,000 shares which are all available as of June 30, 2022. The Plan is intended to permit stock options granted to employees to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”). All options granted under the Plan that are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options. Stock options are granted at an exercise price equal to the fair market value of the Company’s common stock on the date of grant, typically vest over periods up to 4 years and are typically exercisable up to 10 years.

 

 

There were no options granted during the six months ended June 30, 2022 and 2021, respectively.

 

The following table summarizes all stock option activity of the Company for the six months ended June 30, 2022:

 

           Weighted 
       Weighted   Average 
       Average   Remaining 
   Number   Exercise   Contractual 
   of Shares   Price   Life (Years) 
             
Outstanding, December 31, 2021   27,174,938   $0.19    1.53 
                
Granted   -    -    - 
                
Exercised   (500,000)   -    - 
                
Forfeited   -   $-    - 
                
Outstanding, June 30, 2022   26,674,938   $0.20    1.01 
                
Exercisable, June 30, 2022   26,524,938   $0.20    0.99 

 

 

As of June 30, 2022 and 2021, the aggregate intrinsic value of the Company’s outstanding options was minimal. The aggregate intrinsic value will change based on the fair market value of the Company’s common stock.

 

Warrants

 

Warrants are issued to third parties as payment for services, debt financing compensation and conversion and in conjunction with the issuance of common stock. The fair value of each common stock warrant issued for services is estimated on the date of grant using the Black-Scholes option pricing model.

 

 

The following table represents the Company’s warrant activity for the six months ended June 30, 2022:

 

               Weighted 
               Average 
       Weighted   Weighted   Remaining 
   Number   Average   Average   Contractual 
   of Shares   Fair Value   Exercise Price   Life (Years) 
                 
Outstanding, December 31, 2021   10,174,259              -   $0.08    2.36 
                     
Granted   -    -    -    - 
                     
Exercised   (5,203,256)    -    -    - 
                     
Forfeited   -    -    -    - 
                     
Expired   (1,085,180)   -   $0.15    - 
                     
Outstanding, June 30, 2022   3,885,823    -   $0.08    1.75 
                     
Exercisable, June 30, 2022   3,885,823    -   $0.08    1.75